Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | EDNRA | P25101 | 3/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | BCL2 | P10415 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13191513 | 0.87 | CRHBP (0.41) | CRHBPCRHR2EDNRAPTGS2PTGS1 | |
| SCHEMBL8017544 | 0.86 | CRHBP (0.50) | CRHBPCRHR2TP53PTGS2PTGS1 | |
| SCHEMBL8017542 | 0.86 | CRHBP (0.50) | CRHBPCRHR2TP53PTGS2PTGS1 | |
| SCHEMBL8023972 | 0.86 | CRHBP (0.50) | CRHBPCRHR2TP53PTGS2PTGS1 | |
| SCHEMBL8017540 | 0.86 | CRHBP (0.50) | CRHBPCRHR2TP53PTGS2PTGS1 | |
| SCHEMBL3799748 | 0.81 | CRHBP (0.37) | CRHBPCRHR2EDNRA | |
| SCHEMBL7257012 | 0.73 | CRHBP (0.72) | CRHBPCRHR2PTGS2POLBPTGS1 | |
| SCHEMBL7256885 | 0.73 | CRHBP (0.72) | CRHBPCRHR2PTGS2POLBPTGS1 | |
| SCHEMBL7257013 | 0.73 | CRHBP (0.72) | CRHBPCRHR2PTGS2POLBPTGS1 | |
| SCHEMBL7255719 | 0.73 | CRHBP (0.49) | CRHBPCRHR2EDNRAPTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | CYCS, CHN2, TUBA3C | CRHBP 1545/4885CRHR2 2699/4885EGFR 1621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.